Form 4: Schwab Officer Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Paul V. Woolway, MD, Chief Banking Officer at Charles Schwab, reported multiple stock transactions including vesting of restricted stock units, option exercises, and sales under a pre-arranged trading plan.
Summary
- Paul V. Woolway, MD, Chief Banking Officer of The Charles Schwab Corporation, reported several transactions in SCHW common stock and derivative securities.
- On March 1, 2026, 8,156 shares were acquired due to the vesting of performance-based restricted stock units (PBRSUs) from the 2022 Stock Incentive Plan, reflecting achievement of performance goals for the period ending December 31, 2025.
- Concurrently, 2,030 shares were withheld by the company to cover tax withholding obligations related to the PBRSU vesting, at a price of $90.305 per share.
- On March 2, 2026, 15,884 shares were acquired through the exercise of nonqualified stock options granted under the 2013 Stock Incentive Plan, at an exercise price of $52.05 per share. These shares were then contributed to a revocable trust.
- Also on March 2, 2026, 15,189 new nonqualified stock options were granted under the 2022 Stock Incentive Plan, vesting in four equal annual installments starting from the first anniversary of the grant date.
- A total of 22,010 shares were sold between March 2 and March 3, 2026, at weighted average prices ranging from $94.23 to $96.0013.
- All reported sales were executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Woolway on November 24, 2025.
- Following these transactions, Mr. Woolway's indirect beneficial ownership by Trust decreased, while direct ownership of options changed.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral-to-slightly positive filing. While there are significant sales, they are pre-planned and offset by the vesting of performance-based awards and new option grants, indicating routine compensation and personal financial management rather than a negative outlook on the company.
Positives
- Acquisition of 8,156 shares from PBRSU vesting indicates achievement of performance goals for the period ended December 31, 2025.
- Exercise of 15,884 stock options at $52.05 and subsequent sale at higher prices (e.g., $94-$96) indicates a profitable transaction for the insider.
- Grant of 15,189 new nonqualified stock options aligns the officer's interests with long-term company performance.
Negatives
- Significant sales of 22,010 shares by a key officer, even if pre-planned, represent a reduction in direct equity exposure.
- 2,030 shares were withheld for tax obligations, reducing the net shares received from vesting.
Future Outlook
The filing does not provide specific forward-looking statements or guidance regarding the company's future performance, focusing instead on past and planned insider transactions.
Management Comments
- Shares acquired on the vesting of performance-based restricted stock units ("PBRSUs") granted under the company's 2022 Stock Incentive Plan, reflecting the achievement by the reporting person of the performance goal over a three-year performance period ended December 31, 2025.
- The company withheld shares of common stock from the reporting person to pay the tax withholding obligations related to the vesting of the PBRSUs.
- Reflects the contribution of 15,884 shares received upon exercise of the options to a revocable trust.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-l trading plan adopted by the reporting person on November 24, 2025.
- The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Industry Context
StockSavvy.ai notes that insider transactions, particularly those executed under Rule 10b5-1 plans, are common in the financial services industry as a means for executives to manage their personal equity holdings while adhering to insider trading regulations. These transactions typically reflect personal financial planning rather than a direct signal about the company's immediate operational outlook or competitive position.
Comparison to Industry Standards
- StockSavvy.ai observes that the use of performance-based restricted stock units and nonqualified stock options as part of executive compensation packages is standard practice across the financial services sector, including major competitors like Fidelity, Vanguard, and Morgan Stanley.
- The adoption of a Rule 10b5-1 trading plan is also a widely accepted mechanism for insiders to sell shares in a pre-scheduled, compliant manner, reducing concerns about opportunistic trading.
- The specific volume of shares traded by Mr. Woolway is consistent with a senior executive managing a substantial equity stake in a large financial institution.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Appointment | Paul V. Woolway appointed P. Blake Allen, Kristopher R. Tate, and Lucy Yiheng Liu as attorneys-in-fact to prepare, execute, and submit SEC Forms 3, 4, and 5 on his behalf, and to obtain information regarding his transactions in company equity securities. | 2025-12-11 | Streamlines the process for the officer to comply with Section 16 reporting requirements, ensuring timely and accurate filings. |
Related Party Transactions
- Shares held indirectly by Trust, ESPP, Son 1, and Son 2 are noted, indicating beneficial ownership through related parties.
Stakeholder Impact
- Shareholders: Provides transparency into insider trading activity, which can influence investor sentiment, though pre-planned sales typically have less impact than unexpected sales.
- Employees: The vesting of PBRSUs and grant of stock options are part of the company's executive compensation structure, which can motivate performance.
Next Steps
- Future vesting of the newly granted 15,189 nonqualified stock options, which vest in four equal annual installments starting from the first anniversary of the grant date (March 2, 2027).
- Potential future sales under the existing Rule 10b5-1 trading plan or new plans.
Key Dates
| Date | Description |
|---|---|
| 2025-11-24 | Rule 10b5-1 trading plan adopted by Paul V. Woolway. |
| 2025-12-11 | Power of Attorney signed by Paul V. Woolway, appointing attorneys-in-fact for SEC filings. |
| 2025-12-31 | End of the three-year performance period for performance-based restricted stock units (PBRSUs). |
| 2026-03-01 | Vesting of performance-based restricted stock units (PBRSUs) and acquisition of 8,156 shares; 2,030 shares withheld for tax obligations. |
| 2026-03-02 | Exercise of 15,884 nonqualified stock options; grant of 15,189 new nonqualified stock options; sale of 7,942 shares at $94.23 and 7,942 shares at $96.0013. |
| 2026-03-03 | Sale of 3,626 shares at $94.4144 and 2,500 shares at $94.8904. |
| 2028-03-01 | Expiration date for nonqualified stock options granted under the 2013 Stock Incentive Plan. |
| 2036-03-02 | Expiration date for nonqualified stock options granted under the 2022 Stock Incentive Plan. |
Recommendation
holdThis Form 4 details routine insider transactions, including the vesting of performance-based awards, exercise of stock options, and sales executed under a pre-arranged Rule 10b5-1 trading plan. These activities are typical for senior executives managing their compensation and personal finances and do not provide new fundamental information about The Charles Schwab Corporation's operational performance or strategic direction. Therefore, based solely on this filing, a seasoned investor would likely maintain their current position, as it does not present a compelling reason to alter investment strategy.
Keywords
Charles Schwab, SCHW, Insider Trading, Form 4, Stock Options, Restricted Stock Units, 10b5-1 Plan, Officer Transactions, Paul V. Woolway, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.